U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

SRX5495172: GSM3660920: SHP2i_3; Mus musculus; RNA-Seq
1 ILLUMINA (NextSeq 500) run: 23.4M spots, 3.4G bases, 1.3Gb downloads

Submitted by: NCBI (GEO)
Study: SHP2 Blockade Sensitizes Metastatic Triple Negative Breast Cancer to PI3K Inhibition
show Abstracthide Abstract
Next Generation Sequencing was applied to investigate the effects of PI3K inhibition and/or SHP2 inhibition on the mouse mammary carcinoma 4T1. Overall design: RNA-Seq in 4 different treatment conditions to investigate PI3K/SHP2 signalling role in primary tumors.
Sample: SHP2i_3
SAMN11089830 • SRS4464830 • All experiments • All runs
Organism: Mus musculus
Library:
Instrument: NextSeq 500
Strategy: RNA-Seq
Source: TRANSCRIPTOMIC
Selection: cDNA
Layout: PAIRED
Construction protocol: RNeasy Plus Mini Kit (Qiagen, #74136) and sample quality controlled on an Agilent 2100 Bioanalyzer system with the RNA6000 Nano kit (Agilent, #5067-1511). mRNA isolation was performed with the NEBNext Poly(A) mRNA magnetic isolation module (NEB, #E7490) and libraries prepared with the NEBNext Ultra II Directional RNA Library Prep kit (NEB, #E7765) according to the manufacturer's recommendations Samples were individually barcoded during library preparation using NEBNext Multiplex Oligos for Illumina Index Primers Sets 1 and 2 (NEB, #E7335 and #E7500). Library quality control was performed with the DNA1000 kit (Agilent, #5067-1504) on the Agilent 2100 Bioanalyzer system.
Experiment attributes:
GEO Accession: GSM3660920
Links:
Runs: 1 run, 23.4M spots, 3.4G bases, 1.3Gb
Run# of Spots# of BasesSizePublished
SRR869942923,376,5303.4G1.3Gb2023-04-25

ID:
7418843

Supplemental Content

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...